Examkin

Soru

Zorluk: OrtaDiagnostic Workup and Test Sequencing

A 58-year-old postmenopausal woman presents to the clinic for evaluation of a newly identified right breast lump. She noticed the firm, painless mass in the upper outer quadrant 2 weeks ago during self-examination. Physical examination confirms a 2-centimeter, non-tender, relatively mobile mass in the right breast with no overlying skin dimpling, nipple retraction, or axillary lymphadenopathy. Her last screening mammogram was 18 months ago and was reported as normal. Arrange the following diagnostic steps in the most appropriate chronological sequence for the evaluation of this patient's new palpable mass.

  1. 1Bilateral diagnostic mammography
  2. 2Targeted breast ultrasonography of the palpable mass
  3. 3Image-guided core needle biopsy
  4. 4Immunohistochemical evaluation for hormone receptor and HER2 status

Cevap

The correct diagnostic sequence begins with broad non-invasive imaging (bilateral diagnostic mammography), followed by focused characterization (targeted ultrasonography), tissue sampling (core needle biopsy), and finally molecular subtyping (immunohistochemical evaluation).
The correct sequence respects the fundamental diagnostic principle of proceeding from least invasive macroscopic assessment to targeted characterization, followed by definitive tissue sampling. Bilateral diagnostic mammography ensures no other subclinical lesions exist. Targeted ultrasonography then focuses precisely on the known mass to distinguish cystic from solid components and plan the biopsy track. The core needle biopsy physically acquires the necessary tissue, allowing the final step of immunohistochemical staining to identify actionable cellular targets.

Adım Adım Çözüm

1
Perform bilateral diagnostic mammography.
Assesses the palpable mass and screens for multicentric or contralateral clinically occult disease, such as microcalcifications.
It is the standard initial imaging modality for evaluating palpable breast masses in women aged 30 years and older.
2
Perform targeted breast ultrasonography.
Differentiates solid from cystic lesions and further characterizes the morphological features of the mass.
Provides a high-resolution view of the specific area of concern and acts as a direct guide for mapping the optimal biopsy route.
3
Perform an image-guided core needle biopsy.
Obtains intact tissue architecture for microscopic examination.
A definitive histologic diagnosis is required prior to initiating any oncologic treatment for a suspicious solid mass.
4
Conduct immunohistochemical evaluation.
Determines estrogen receptor, progesterone receptor, and HER2 expression levels.
These molecular biomarkers dictate the administration of targeted biological therapies and endocrine therapies.

Anahtar Kavram

The diagnostic sequencing of a new palpable breast mass in women aged 30 and older involves a stepwise progression from broad macroscopic imaging (mammography) to targeted characterization (ultrasonography), tissue acquisition (core biopsy), and finally molecular pathology.
Bu soruyu puanla

Konular

Diagnostic Workup and Test Sequencing

Bu konudan daha fazla soru